Anxiety Clinical Trial
Official title:
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
The purpose of this study is to examine the feasibility, acceptability, and utility of pharmacogenomic (PGX) testing (specifically for the cytochrome P450 2D6 and 2C19 genes) prior to initiating treatment with an antidepressant (AD) among children and adolescents in the University of Florida Child Psychiatry clinics.
This project will assess the feasibility of implementing pharmacogenomic testing (PGX) for
specific genes involved in the metabolism of antidepressants (CYP2D6 and CYP2C19) into the
child psychiatry clinic at UF.
Although not widely implemented to date, naturalistic studies in adult psychiatry populations
have shown that PGX testing can improve patient outcomes, increase medication adherence, and
reduce costs. However, there have been no studies of psychiatry-focused PGX testing in
children. One in every four children and adolescents suffers from a mental illness (more than
half have a mood or anxiety disorder) that is severe enough to impact their functioning at
school, at home, or in other important areas. Although psychotherapy remains the first line
treatment for children with mild or uncomplicated symptoms, the use of psychotropic
medications in children has increased steadily over the last decade. These medications are
effective for many children, but carry a substantial risk of side effects, including
gastrointestinal, cognitive, systemic, and psychiatric (including treatment emergent suicidal
ideation). For most treatment responders, improvement is typically seen four to eight weeks
after the target dose has been achieved (twelve weeks for obsessive compulsive disorder).
Thus, identifying the best medication options prior to treatment initiation could decrease
the likelihood of side effects severe enough to require medication discontinuation or
changes, and minimize the time to response. In this study, 50 children and adolescents with
major depression, anxiety, or obsessive compulsive disorders who are beginning treatment with
a new antidepressant will be recruited and PGX testing will be conducted. Twenty five
children will be randomized to receive PGX testing prior to starting/changing medications and
25 to receive treatment as usual (these children will receive their PGX results at the end of
12 weeks). Members of the UF Health Personalized Medicine Program will provide education to
the prescribing clinicians about PGX testing and will create patient-specific consultations
regarding the PGX results.
Assess clinicians' and parents' willingness to use PGX testing in making treatment decisions,
as well as their knowledge and beliefs about PGX testing (pre-and post-study). Also assess,
as pilot data for a larger randomized controlled trial, differences in side effect profiles,
treatment adherence, and symptom improvements between the PGX cases and controls.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04579354 -
Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Completed |
NCT05881681 -
A Mindfulness Approach to UA for Afro-descendants
|
N/A | |
Active, not recruiting |
NCT04961112 -
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
|
N/A | |
Completed |
NCT05980845 -
The Effect Nature Sounds and Music on Hemodialysis Patients
|
N/A | |
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT05449002 -
Digital Single Session Intervention for Youth Mental Health
|
N/A | |
Completed |
NCT05585749 -
Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients
|
N/A | |
Terminated |
NCT03272555 -
WILD 5 Wellness: A 30-Day Intervention
|
N/A | |
Recruiting |
NCT05997849 -
Development of a Multiplatform Mental Health Mobile Tool
|
N/A | |
Completed |
NCT06421233 -
The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels
|
N/A |